These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 33666664)

  • 1. Evaluation of Absolute Lymphocyte Count at Diagnosis and Mortality Among Patients With Localized Bone or Soft Tissue Sarcoma.
    Brewster R; Purington N; Henry S; Wood D; Ganjoo K; Bui N
    JAMA Netw Open; 2021 Mar; 4(3):e210845. PubMed ID: 33666664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Posttreatment Lymphopenia and Elevated Neutrophil-to-Lymphocyte Ratio With Poor Clinical Outcomes in Patients With Human Papillomavirus-Negative Oropharyngeal Cancers.
    Lin AJ; Gang M; Rao YJ; Campian J; Daly M; Gay H; Oppelt P; Jackson RS; Rich J; Paniello R; Zevallos J; Hallahan D; Adkins D; Thorstad W
    JAMA Otolaryngol Head Neck Surg; 2019 May; 145(5):413-421. PubMed ID: 30920592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can Multistate Modeling of Local Recurrence, Distant Metastasis, and Death Improve the Prediction of Outcome in Patients With Soft Tissue Sarcomas?
    Posch F; Leitner L; Bergovec M; Bezan A; Stotz M; Gerger A; Pichler M; Stöger H; Liegl-Atzwanger B; Leithner A; Szkandera J
    Clin Orthop Relat Res; 2017 May; 475(5):1427-1435. PubMed ID: 28083752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Lymphopenia With Risk of Mortality Among Adults in the US General Population.
    Zidar DA; Al-Kindi SG; Liu Y; Krieger NI; Perzynski AT; Osnard M; Nmai C; Anthony DD; Lederman MM; Freeman ML; Bonomo RA; Simon DI; Dalton JE
    JAMA Netw Open; 2019 Dec; 2(12):e1916526. PubMed ID: 31790569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. One-year mortality in patients with bone and soft tissue sarcomas as an indicator of delay in presentation.
    Nandra R; Hwang N; Matharu GS; Reddy K; Grimer R
    Ann R Coll Surg Engl; 2015 Sep; 97(6):425-33. PubMed ID: 26274756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic factors and impact of surgery in patients with metastatic soft tissue sarcoma at diagnosis: A population-based cohort study.
    Zhang L; Akiyama T; Fukushima T; Iwata S; Tsuda Y; Takeshita K; Kawai A; Tanaka S; Kobayashi H
    Jpn J Clin Oncol; 2021 May; 51(6):918-926. PubMed ID: 33774673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. D-dimer levels as a prognostic factor for determining oncological outcomes in musculoskeletal sarcoma.
    Morii T; Mochizuki K; Tajima T; Ichimura S; Satomi K
    BMC Musculoskelet Disord; 2011 Nov; 12():250. PubMed ID: 22044610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What is the Incidence of Suicide in Patients with Bone and Soft Tissue Cancer? : Suicide and Sarcoma.
    Siracuse BL; Gorgy G; Ruskin J; Beebe KS
    Clin Orthop Relat Res; 2017 May; 475(5):1439-1445. PubMed ID: 27896676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Longer duration of symptoms at the time of presentation is not associated with worse survival in primary bone sarcoma.
    Lawrenz JM; Styron JF; Parry M; Grimer RJ; Mesko NW
    Bone Joint J; 2018 May; 100-B(5):652-661. PubMed ID: 29701086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations of routine blood tests in adult patients with soft tissue sarcomas: relationships to cytokine serum levels and prognostic significance.
    Ruka W; Rutkowski P; Kaminska J; Rysinska A; Steffen J
    Ann Oncol; 2001 Oct; 12(10):1423-32. PubMed ID: 11762815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Impact of Radiation Therapy on Lymphocyte Count and Survival in Metastatic Cancer Patients Receiving PD-1 Immune Checkpoint Inhibitors.
    Pike LRG; Bang A; Mahal BA; Taylor A; Krishnan M; Spektor A; Cagney DN; Aizer AA; Alexander BM; Rahma O; Balboni T; Ott PA; Hodi FS; Schoenfeld JD
    Int J Radiat Oncol Biol Phys; 2019 Jan; 103(1):142-151. PubMed ID: 30227198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Persistent lymphopenia after diagnosis of sepsis predicts mortality.
    Drewry AM; Samra N; Skrupky LP; Fuller BM; Compton SM; Hotchkiss RS
    Shock; 2014 Nov; 42(5):383-91. PubMed ID: 25051284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymphopenia as a prognostic factor for overall survival in advanced carcinomas, sarcomas, and lymphomas.
    Ray-Coquard I; Cropet C; Van Glabbeke M; Sebban C; Le Cesne A; Judson I; Tredan O; Verweij J; Biron P; Labidi I; Guastalla JP; Bachelot T; Perol D; Chabaud S; Hogendoorn PC; Cassier P; Dufresne A; Blay JY;
    Cancer Res; 2009 Jul; 69(13):5383-91. PubMed ID: 19549917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preoperative platelet-lymphocyte ratio is superior to neutrophil-lymphocyte ratio as a prognostic factor for soft-tissue sarcoma.
    Que Y; Qiu H; Li Y; Chen Y; Xiao W; Zhou Z; Zhang X
    BMC Cancer; 2015 Oct; 15():648. PubMed ID: 26432433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (SARC028): a multicentre, two-cohort, single-arm, open-label, phase 2 trial.
    Tawbi HA; Burgess M; Bolejack V; Van Tine BA; Schuetze SM; Hu J; D'Angelo S; Attia S; Riedel RF; Priebat DA; Movva S; Davis LE; Okuno SH; Reed DR; Crowley J; Butterfield LH; Salazar R; Rodriguez-Canales J; Lazar AJ; Wistuba II; Baker LH; Maki RG; Reinke D; Patel S
    Lancet Oncol; 2017 Nov; 18(11):1493-1501. PubMed ID: 28988646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone versus soft-tissue sarcomas in the elderly.
    Torigoe T; Terakado A; Suehara Y; Kurosawa H; Yazawa Y; Takagi T
    J Orthop Surg (Hong Kong); 2010 Apr; 18(1):58-62. PubMed ID: 20427836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biological significance and prognostic relevance of peripheral blood neutrophil-to-lymphocyte ratio in soft tissue sarcoma.
    Chan JY; Zhang Z; Chew W; Tan GF; Lim CL; Zhou L; Goh WL; Poon E; Somasundaram N; Selvarajan S; Sittampalam K; Chin F; Teh J; Tan MH; Soo KC; Teo M; Farid M; Quek R
    Sci Rep; 2018 Aug; 8(1):11959. PubMed ID: 30097600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphocyte Count Kinetics, Factors Associated with the End-of-Radiation-Therapy Lymphocyte Count, and Risk of Infection in Patients with Solid Malignant Tumors Treated with Curative-Intent Radiation Therapy.
    Terrones-Campos C; Ledergerber B; Vogelius IR; Specht L; Helleberg M; Lundgren J
    Int J Radiat Oncol Biol Phys; 2019 Nov; 105(4):812-823. PubMed ID: 31344435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Semi-Quantitative Calculations of Primary Tumor Metabolic Activity Using F-18 FDG PET/CT as a Predictor of Survival in 92 Patients With High-Grade Bone or Soft Tissue Sarcoma.
    Andersen KF; Fuglo HM; Rasmussen SH; Petersen MM; Loft A
    Medicine (Baltimore); 2015 Jul; 94(28):e1142. PubMed ID: 26181552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CT Attenuation and Cross-sectional-area Index of the Pectoralis Are Associated With Prognosis in Sarcoma Patients.
    Jo S; Sebro R
    Anticancer Res; 2021 Apr; 41(4):1927-1935. PubMed ID: 33813398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.